Grants and contracts awarded to Yale School of Medicine

March/April, 2010


Federal

  • Steven L. Bernstein, NIH, Treating Low-Income Smokers in the Hospital Emergency Department, 5 years, $3,343,594
  • Linda K. Bockenstedt, NIH, Real-Time Imaging Analysis of Vector-Borne Lyme Borreliosis Pathogenesis and Persistence, 5 years, $2,068,750
  • Sonia Caprio, NIH, Neural Functioning of Feeding Centers in Obese Youth, 5 years, $2,726,025
  • Jessica A. Cardin, NIH, Impact of Local Network Dynamics on Visual Cortex Function, 3 years, $607,988
  • Katarzyna Chawarska, NIH, Development of Face Processing in Infants with Autism Spectrum Disorders, 5 years, $2,068,750
  • Jersey Chen, Agency for Healthcare Research and Quality/DHHS,Geographic Variation in Use of Imaging with Cardiac Stress Testing, 5 years, $723,060
  • Nihal C. deLanerolle, Office of Naval Research, Understanding the Biomechanical, Biochemical, Physiological and Functional Consequences of Explosive Blast Injury to the Human Brain—PREVENT Phase II, 2 years, $1,409,700
  • Gary V. Desir, NIH, Renalase Deficiency and Cardiovascular Complications of Chronic Kidney Disease, 1 year, $500,000
  • Sabrina Diano, NIH, A Carboxypeptidase in the Regulation of Hypothalamic Circuitry, 4 years, $1,443,989
  • Robert Dubrow, NIH, Patterns of Care and Outcomes for Glioblastoma Patients, 2 years, $165,500
  • Veraragavan P. Eswarakumar, NIH, Mechanisms of FGFR2 Signaling in Craniofacial Development, 5 years, $2,079,310
  • Adrienne S. Ettinger, NIH, Genetic and Epigenetic Modifiers of Maternal–Fetal Transfer of Toxicants & Outcomes, 20 months, $256,017
  • Carlos A.V. Fragoso, NIH, Defining Chronic Obstructive Pulmonary Disease in Older Persons, 2 years, $135,710
  • Patrick G. Gallagher, NIH, Molecular Biology of Human Erythrocyte Alpha Spectrin, 4 years, $1,655,000
  • Peter M. Glazer, NIH, Epigenetic Regulation in Hypoxic Cancer Cells, 5 years, $1,682,723
  • Michelle Hampson, NIH, Biofeedback of Real-Time fMRI to Control Activity in the Orbitofrontal Cortex, 2 years, $496,500
  • Kazue Hashimoto-Torii, NIH, Mechanisms Leading to Cortical Dysplasia in Fetal Alcohol Spectrum Diseases, 2 years, $176,874
  • William H. Konigsberg, NIH, Molecular Biology and Structure of DNA Replicase, 4years, $1,456,400
  • Gary Kupfer, NIH, HTLV-I Tax1 Protein Chemosensitization of p53 Mutant Tumors,2 years, $395,959
  • Janghoo Lim, NIH, The Role of Nemo-Like Kinase in Neurodegeneration,3 years, $249,000
  • Steven Marans, Substance Abuse and Mental Health Services Administration, Childhood Violent Trauma Center, 3 years, $1,799,997
  • James C. McPartland, NIH, The Developmental Neuroscience of Social Perception in Infants At Risk for Autism, 4 years, $728,429
  • Peter T. Morgan, NIH, Modafinil, Sleep Architecture, and Cocaine Relapse,5 years, $2,558,685
  • Walther H. Mothes, NIH, A Novel TRIM Protein Involved in Innate Immunity, 2 years, $496,500
  • Michael H. Nathanson, NIH, A Confocal Endomicroscope for Clinical Research, 1 year, $159,900
  • Kitt Falk Petersen, NIH, Mechanisms of Insulin Resistance in the Aged, 5 years, $1,696,375
  • Marc I. Rosen, NIH, Benefits Management for People with Psychiatric Disabilities, 3 years, $480,324 
  • Joseph Santos-Sacchi, NIH, Membrane Properties of Cells Comprising the OHC System, 5ears, $2,294,887 
  • William C. Sessa, NIH, MicroRNA Regulation of Endothelial Functions, 4 years, $1,904,610
  • Gerald I. Shulman, NIH, Cellular Mechanisms of Insulin Resistance in Humans, 5 years, $764,317
  • Stefan Somlo, NIH, A Forward Genetic Screen for PKD Pathways in Mice Using the PiggyBac Transposon, 1 year, $500,000
  • Bing Su, Department of the Army, The Role of mTOR Signaling in the Regulation of RAG Expression and Genomic Stability during B Lymphocyte Development, 3 years, $1,198,036
  • Tami P. Sullivan, Department of Justice, Achieving Successful Researcher–Practitioner Partnerships that Strengthen Practice and Policy: Lessons Learned from the Field, 2 years, $343,565
  • Yulia Surovtseva, NIH, Analysis of Mammalian Mitochondrial Transcription Machinery, 2 years, $99,316
  • Benjamin A. Toll, NIH, Advancing Tobacco and Cancer Control: Reducing Alcohol Use to Promote Smoking Cessation, 2 years, $798,162
  • Benjamin E. Turk, NIH, Global Peptide Microarray Profiling of Tyrosine Kinase Deregulated in Cancer, 2 years, $359,962
  • Anthony N. Van den Pol, NIH, Arcuate Nucleus Glutamatergic Neurons Modulate Energy Homeostasis, 4 years, $1,455,158
  • Andrea H. Weinberger, NIH, Gender Differences in the Association of Depression to Transitions in Smoking, 2 years, $70,750
  • John J. Wysolmerski, Department of Defense, Effects of Nuclear Parathyroid Hormone-Related Protein Signaling in Breast Cancer, 2 years, $620,626
  • Andrew Xiao, NIH, A Novel Enzymatic Activity of WSTF and its Role in Tumorigenesis, 3 months, $72,040
  • Jiansong Xu, NIH, fMRI and DTI Study on Neural Predictor of Treatment Outcome in Cocaine Dependence, 5 years, $801,726
  • Hongyu Zhao, NIH, Statistical Methods to Map Genes for Complex Traits, 4 years, $1,406,752

Non-Federal

  • Marcus W. Bosenberg, Pennsylvania State University, Targeted Chemoprevention for Melanoma, 5 years, $311,414
  • Igor E. Brodsky, Harvard Medical School, Inflammasome Activation byYersiniaVirulence Factors, 2 years, $291,085
  • R. Todd Constable, The John B. Pierce Laboratory Inc., The Role of the Amygdala in Weight Gain Susceptibility, 5 years, $67,057
  • Lynn Cooley, Howard Hughes Medical Institute, Yale Medical Research Scholars Program, 4 years, $700,000
  • Michael P. DiGiovanna, Connecticut Breast Health Initiative Inc.,Combination Targeting of IGF-1 Receptor and HER2 in Breast Cancer, 1 year, 50,000
  • Marie E. Egan, Cystic Fibrosis Foundation, A Model of Chronic Airway Inflammation in CFTR-/- Mice, 1 year, $43,200
  • Brian W. Forsyth, American Medical Association Foundation, An SMS-Based Peer Support Group: A Pilot Project Using Mobile Technology to Increase Social Support for HIV-Positive Women, 1 year, $2,010
  • Gerald Friedland, Albert Einstein College of Medicine, Molecular Epidemiology of HIV-Associated Extensively Drug Resistant Tuberculosis in Rural South Africa, 1 year, $43,813
  • David C. Glahn, Southwest Foundation for Biomedical Research,Identification of Novel Micrornas Associated with Brain Structure and Function, 6 years, $19,264
  • Jeffrey R. Gruen, University of California–San Diego, Creating a Pediatric Imaging–Genomics Data Resource, 6 months, $221,639
  • Yiyun H. Huang, University of Montana, Positron Emission Tomography Imaging for ALS Therapy, 10 months, $72,000
  • Leonard K. Kaczmarek, FRAXA Research Foundation, Development of Pharmacological Activators for FMRP-Regulated Potassium Channels, 1 year, 45,000
  • Jason W. Mastaitis, Juvenile Diabetes Research Foundation International, Investigation of the Role of Hypothalamic MAP Kinase in Counter-regulation, 2 years, $47,704
  • Linda C. Mayes, Baylor College of Medicine, Maternal Brain and Behavioral Responses to Infant Cues in Cocaine-Exposed Mothers, 5 years, $377,281
  • Michael J. Paidas, CerviLenz Inc., Establishing the Utility of Cervilenz as a Predictor of Short Cervical Length and Preterm Delivery in the Mid–Second Trimester of Pregnancy (CL-1003), 20 months, $200,005
  • Lubna Pal, Virginia Commonwealth University, Pharmacogenetics of Metformin Action in PCOS, 1 year, $34,126 
  • Robert S. Sherwin, The John B. Pierce Laboratory Inc., The Role of the Amygdala in Weight-Gain Susceptibility, 5 years, $62,844
  • Rajita Sinha, The John B. Pierce Laboratory Inc., The Role of the Amygdala in Weight-Gain Susceptibility, 5 years, $776,061
  • Barbara Szepietowska, Juvenile Diabetes Research Foundation International, Role of EphA5 in Hypoglycemia, 2 years, $51,004
  • Hugh S. Taylor, Brigham and Women’s Hospital, The Kronos Early Estrogen Prevention Study (KEEPS) Mammographic Density and Breast Health Ancillary Study, 10 months, $8,250
  • Wang-Jing Xiao, Alfred P. Sloan Foundation, Sloan–Swartz Annual Meeting 2010 on Computational Neuroscience, 7 months, $25,047